Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 27, 2017 16:10 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Pharmaceuticals Announces its Participation at the Global Mizuho Investor Conference

ROCKVILLE, Md., Nov. 27, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will participate in investor...
November 21, 2017 16:10 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 29th Annual Piper Jaffray Healthcare Conference

ROCKVILLE, Md., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will participate in a fireside...
November 09, 2017 17:48 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo to Host 2017 R&D Day on November 16 in New York

ROCKVILLE, Md., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced that it will host its 2017 R&D Day...
November 01, 2017 06:30 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Reports Third Quarter 2017 Financial Results

Company Increases 2017 Financial Guidance Based on Strong Performance Year to Date Study Results for VTS-270 for Niemann-Pick Disease Type C1 Published in The Lancet CPP-1X/sulindac Granted...
October 23, 2017 16:05 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Announces Third Quarter 2017 Earnings Call

ROCKVILLE, Md., Oct. 23, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced that it will host its third quarter 2017...
September 28, 2017 17:34 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Pharmaceuticals Announces FDA Acceptance of sNDA for AMITIZA in Children with Pediatric Functional Constipation, with Priority Review Designation

ROCKVILLE, Md., Sept. 28, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced that the U.S. Food and Drug...
September 27, 2017 20:43 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Pharmaceuticals Announces Presentation at Deutsche Bank’s 25th Annual Leveraged Finance Conference

ROCKVILLE, Md., Sept. 27, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that the company will participate in...
September 21, 2017 08:25 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2017 Leerink Partners Roundtable Series: Rare Disease & Immuno-Oncology

ROCKVILLE, Md., Sept. 21, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will participate in a fireside...
September 20, 2017 16:15 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Pharmaceuticals Appoints Alex Driggs as General Counsel

ROCKVILLE, Md., Sept. 20, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced the appointment of Alex Driggs to...
September 19, 2017 16:15 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2017 Cantor Fitzgerald Global Healthcare Conference

ROCKVILLE, Md., Sept. 19, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...

Next Page keyboard_arrow_right